Cite
HARVARD Citation
Bouchet, A. et al. (2022). Evolution of humoral lesions on follow-up biopsy stratifies the risk for renal graft loss after antibody-mediated rejection treatment. Nephrology dialysis transplantation. 37 (12), pp. 2555-2568. [Online].